Formal Japanese approvals include first nod worldwide for teneligliptin
This article was originally published in Scrip
Executive Summary
A large group of products given positive recommendations in Japan over the past few months has now been formally approved by the ministry of health, labour and welfare, including Pfizer's Inlyta (axitinib) and Mitsubishi Tanabe Pharma's (MTP) Tenelia (teneligliptin), the latter receiving its first marketing clearance worldwide.